The pathogenicity to mice of three variants of Mengo encephalomyelitis virus

The distribution of infectious virus particles in various tissues of the mouse was determined following the intraperitoneal injection of three plaque variants of Mengo encephalomyelitis virus. When lethal doses were administered, virus appeared first in the spleen and lymph nodes (suggesting that th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular and comparative physiology 1965-04, Vol.65 (2), p.229-235
Hauptverfasser: Colter, John S., Campbell, James B., Hatch, Lorne R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The distribution of infectious virus particles in various tissues of the mouse was determined following the intraperitoneal injection of three plaque variants of Mengo encephalomyelitis virus. When lethal doses were administered, virus appeared first in the spleen and lymph nodes (suggesting that these are the primary target organs for the agents), followed by its appearance in spinal cord and brain, in which tissues the infectious titers increased progressively until the death of the animals. Low levels of virus were sometimes found in lung, heart and kidney at 24–48 hours post‐challenge, but disappeared from these tissues at later times. Virus was never detected in blood or liver, suggesting that the virus moves throughout the animal by way of the lymphatic system. When sub‐lethal doses of virus were injected, it was detectable only in spleen and lymph nodes, and disappeared from these tissues by 8–9 days post‐challenge. The LD50's for the three variants when injected by both the intraperitoneal and intracerebral routes were determined. The I.P.‐LD50's for the L (large plaque former), M (medium plaque former) and S (minute plaque former) variants in 14–16 gm mice were found to be 1, 1–5 × 104 and 2–10 × 104 p.f.u.'s, respectively. The I.C.‐LD50's were essentially the same (1–5 p.f.u.'s) for all three variants. The possibility that the differences in the I.P.‐LD50's may be due to differences in the abilities of the variants to stimulate interferon production or in their sensitivities to its antiviral action is discussed.
ISSN:0095-9898
0021-9541
1553-0809
DOI:10.1002/jcp.1030650209